Major trials of ACE inhibitors in heart failure and myocardial infarction | Download Table
Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure | PLOS ONE
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial - The Lancet
New heart failure agent doubles mortality benefit of ACE inhibitors - PACE-CME
Landmark Trials of ACE inhibitors and Beta-blockers | Download Table
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials | BMC Cardiovascular Disorders | Full Text
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology
SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation | Cleveland Clinic Journal of Medicine
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients - The Lancet
Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategy
Trials of ace inhibitors
ACE inhibitors & ARBs in HFpEF — NERDCAT
Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis | PLOS ONE
Major trials of ARBs in heart failure and myocardial infarction | Download Table
Cause of heart failure in some trials of ACE inhibitors and ARBs | Download Table
Angiotensin-Converting Enzyme Inhibitors or β-Blockers in Heart Failure | Circulation
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials | BMC Cardiovascular Disorders | Full Text
Major trials of ARBs in heart failure and myocardial infarction | Download Table
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials - The Lancet
Major trials of ACE inhibitors in heart failure and myocardial infarction | Download Table
Doses of ACE-inhibitors shown to be effective in large, controlled... | Download Table
Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure | PLOS ONE
